IS2912B - Samsetning og andveiruvirkni umskiptra azaindóloxóediksýrupíperazínafleiðna - Google Patents

Samsetning og andveiruvirkni umskiptra azaindóloxóediksýrupíperazínafleiðna

Info

Publication number: IS2912B
Authority: IS; Iceland
Prior art keywords: composition; antiviral activity; piperazine derivatives; oxoacetic acid; acid piperazine
Prior art date: 2001-02-02

Application number

IS6899A

Other languages

English (en)

Other versions

IS6899A (is

Inventor

Tao Wang

Zhongxing Zhang

Nicholas A Meanwell

John F Kadow

Zhiwei Yin

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-02

Filing date

2003-07-30

Publication date

2014-11-15

2003-07-30 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

2003-07-30 Publication of IS6899A publication Critical patent/IS6899A/is

2014-11-15 Publication of IS2912B publication Critical patent/IS2912B/is

Links

230000000840 anti-viral effect Effects 0.000 title 1
-1 azaindole oxoacetic acid piperazine derivatives Chemical class 0.000 title 1
229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Bioinformatics & Cheminformatics (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IS6899A 2001-02-02 2003-07-30 Samsetning og andveiruvirkni umskiptra azaindóloxóediksýrupíperazínafleiðna IS2912B (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US26618301P	2001-02-02	2001-02-02
US31440601P	2001-08-23	2001-08-23
PCT/US2002/000455 WO2002062423A1 (en)	2001-02-02	2002-01-02	Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives

Publications (2)

Publication Number	Publication Date
IS6899A IS6899A (is)	2003-07-30
IS2912B true IS2912B (is)	2014-11-15

Family

ID=26951680

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6899A IS2912B (is)	2001-02-02	2003-07-30	Samsetning og andveiruvirkni umskiptra azaindóloxóediksýrupíperazínafleiðna

Country Status (32)

Country	Link
US (1)	US20030069266A1 (is)
EP (1)	EP1363705B9 (is)
JP (1)	JP4328527B2 (is)
KR (1)	KR20030079979A (is)
CN (1)	CN100384423C (is)
AR (1)	AR034292A1 (is)
BG (1)	BG66359B1 (is)
BR (1)	BRPI0206636B8 (is)
CA (1)	CA2437524C (is)
CY (1)	CY1113194T1 (is)
CZ (1)	CZ303750B6 (is)
DK (1)	DK1363705T3 (is)
EE (1)	EE05424B1 (is)
ES (1)	ES2387981T3 (is)
HK (1)	HK1056698A1 (is)
HR (1)	HRP20030694A2 (is)
HU (1)	HU229305B1 (is)
IL (2)	IL157029A0 (is)
IS (1)	IS2912B (is)
MX (1)	MXPA03006939A (is)
MY (1)	MY137480A (is)
NO (1)	NO326510B1 (is)
NZ (1)	NZ527193A (is)
PE (1)	PE20020855A1 (is)
PL (1)	PL364279A1 (is)
PT (1)	PT1363705E (is)
RS (1)	RS52489B (is)
RU (1)	RU2303038C2 (is)
SK (1)	SK287900B6 (is)
TW (1)	TWI318978B (is)
WO (1)	WO2002062423A1 (is)
ZA (1)	ZA200305885B (is)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6476034B2 (en) *	2000-02-22	2002-11-05	Bristol-Myers Squibb Company	Antiviral azaindole derivatives
US20030207910A1 (en) *	2001-02-02	2003-11-06	Tao Wang	Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US20040110785A1 (en) *	2001-02-02	2004-06-10	Tao Wang	Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
WO2003072028A2 (en) *	2002-02-23	2003-09-04	Bristol-Myers Squibb Company	Method of treating hiv infection by preventing interaction of cd4 and gp120
US7348337B2 (en)	2002-05-28	2008-03-25	Bristol-Myers Squibb Company	Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
US6900206B2 (en)	2002-06-20	2005-05-31	Bristol-Myers Squibb Company	Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives
RU2423353C1 (ru)	2002-12-20	2011-07-10	Глэксо Груп Лимитед	Новые производные бензазепина
US20050075364A1 (en) *	2003-07-01	2005-04-07	Kap-Sun Yeung	Indole, azaindole and related heterocyclic N-substituted piperazine derivatives
US20050124623A1 (en) *	2003-11-26	2005-06-09	Bender John A.	Diazaindole-dicarbonyl-piperazinyl antiviral agents
US7745625B2 (en) *	2004-03-15	2010-06-29	Bristol-Myers Squibb Company	Prodrugs of piperazine and substituted piperidine antiviral agents
CN1953985B (zh) *	2004-03-15	2010-06-09	布里斯托尔-迈尔斯斯奎布公司	哌嗪和取代的哌啶抗病毒药物的前药
US20050244458A1 (en) *	2004-04-30	2005-11-03	Allergan, Inc.	Sustained release intraocular implants and methods for treating ocular neuropathies
PE20060430A1 (es)	2004-06-09	2006-05-25	Glaxo Group Ltd	Derivados de pirrolopiridina como moduladores de los receptores cannabinoides
BRPI0514695A (pt)	2004-09-03	2008-06-17	Yuhan Corp	derivados de pirrol[3, 2-b]piridina e processos para a preparação destes
US20060100209A1 (en) *	2004-11-09	2006-05-11	Chong-Hui Gu	Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US20060100432A1 (en) *	2004-11-09	2006-05-11	Matiskella John D	Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US7183284B2 (en) *	2004-12-29	2007-02-27	Bristol-Myers Squibb Company	Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents
US7601715B2 (en)	2005-06-22	2009-10-13	Bristol-Myers Squibb Company	Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein
US7396830B2 (en) *	2005-10-04	2008-07-08	Bristol-Myers Squibb Company	Piperazine amidines as antiviral agents
US7851476B2 (en) *	2005-12-14	2010-12-14	Bristol-Myers Squibb Company	Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2 (en)	2006-04-25	2010-10-05	Bristol-Myers Squibb Company	Diketo-piperazine and piperidine derivatives as antiviral agents
US7504399B2 (en) *	2006-06-08	2009-03-17	Bristol-Meyers Squibb Company	Piperazine enamines as antiviral agents
EP2046753A2 (en) *	2006-07-06	2009-04-15	Brystol-Myers Squibb Company	Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
EP2066664A1 (en) *	2006-09-22	2009-06-10	Novartis AG	Heterocyclic organic compounds
US8242124B2 (en)	2008-06-25	2012-08-14	Bristol-Myers Squibb Company	Diketopiperidine derivatives as HIV attachment inhibitors
JP5433690B2 (ja)	2008-06-25	2014-03-05	ブリストル−マイヤーズスクイブカンパニー	抗−ｈｉｖ薬としてのジケト縮合アゾロピペリジンおよびアゾロピペラジン
US8450361B2 (en)	2010-08-06	2013-05-28	Bristol-Myers Squibb Company	Substituted indole and azaindole oxoacetyl piperazinamide derivatives
WO2012075235A1 (en)	2010-12-02	2012-06-07	Bristol-Myers Squibb Company	Alkyl amides as hiv attachment inhibitors
EP2696937B1 (en)	2011-04-12	2017-05-17	VIIV Healthcare UK (No.5) Limited	Thioamide, amidoxime and amidrazone derivatives as hiv attachment inhibitors
ES2609579T3 (es)	2011-08-29	2017-04-21	VIIV Healthcare UK (No.5) Limited	Derivados espiro de diamina bicíclica como inhibidores de la unión del VIH
US8835454B2 (en)	2011-08-29	2014-09-16	Bristol-Myers Squibb Company	Fused bicyclic diamine derivatives as HIV attachment inhibitors
CN104080785B (zh)	2012-02-08	2016-08-31	百时美施贵宝公司	用于制备hiv附着抑制剂哌嗪前药化合物的方法
WO2013138436A1 (en)	2012-03-14	2013-09-19	Bristol-Myers Squibb Company	Cyclolic hydrazine derivatives as hiv attachment inhibitors
WO2014060381A1 (de)	2012-10-18	2014-04-24	Bayer Cropscience Ag	Heterocyclische verbindungen als schädlingsbekämpfungsmittel
JP2016503395A (ja)	2012-10-31	2016-02-04	バイエル・クロップサイエンス・アクチェンゲゼルシャフト	病害生物防除剤としての複素環化合物
WO2016004305A2 (en)	2014-07-02	2016-01-07	Pharmacyclics Llc	Inhibitors of bruton's tyrosine kinase
US11862306B1 (en)	2020-02-07	2024-01-02	Cvs Pharmacy, Inc.	Customer health activity based system for secure communication and presentation of health information

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5563142A (en) *	1989-12-28	1996-10-08	The Upjohn Company	Diaromatic substituted compounds as anti-HIV-1 agents
GB9420521D0 (en) *	1994-10-12	1994-11-30	Smithkline Beecham Plc	Novel compounds
TW406075B (en) *	1994-12-13	2000-09-21	Upjohn Co	Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
AU772295B2 (en) *	1999-05-21	2004-04-22	Scios Inc.	Indole-type derivatives as inhibitors of p38 kinase
US6469006B1 (en) *	1999-06-15	2002-10-22	Bristol-Myers Squibb Company	Antiviral indoleoxoacetyl piperazine derivatives
HUP0203375A3 (en) *	1999-07-28	2005-03-29	Aventis Pharm Prod Inc	Substituted oxoazaheterocyclyl compounds
EP1263759B1 (en) *	1999-12-24	2010-09-08	Aventis Pharma Limited	Azaindoles
US20020061892A1 (en) *	2000-02-22	2002-05-23	Tao Wang	Antiviral azaindole derivatives
WO2002004440A1 (en) *	2000-07-10	2002-01-17	Bristol-Myers Squibb Company	Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
US6825201B2 (en) *	2001-04-25	2004-11-30	Bristol-Myers Squibb Company	Indole, azaindole and related heterocyclic amidopiperazine derivatives

2002
- 2002-01-02 US US10/038,306 patent/US20030069266A1/en not_active Abandoned
- 2002-01-02 MX MXPA03006939A patent/MXPA03006939A/es active IP Right Grant
- 2002-01-02 RS YU60903A patent/RS52489B/en unknown
- 2002-01-02 NZ NZ527193A patent/NZ527193A/en not_active IP Right Cessation
- 2002-01-02 EP EP02707413A patent/EP1363705B9/en not_active Expired - Lifetime
- 2002-01-02 PT PT02707413T patent/PT1363705E/pt unknown
- 2002-01-02 CN CNB028078268A patent/CN100384423C/zh not_active Expired - Lifetime
- 2002-01-02 WO PCT/US2002/000455 patent/WO2002062423A1/en active IP Right Grant
- 2002-01-02 EE EEP200300359A patent/EE05424B1/xx unknown
- 2002-01-02 ES ES02707413T patent/ES2387981T3/es not_active Expired - Lifetime
- 2002-01-02 JP JP2002562428A patent/JP4328527B2/ja not_active Expired - Lifetime
- 2002-01-02 BR BR0206636-0 patent/BRPI0206636B8/pt not_active IP Right Cessation
- 2002-01-02 CA CA2437524A patent/CA2437524C/en not_active Expired - Lifetime
- 2002-01-02 KR KR10-2003-7010208A patent/KR20030079979A/ko not_active Application Discontinuation
- 2002-01-02 SK SK959-2003A patent/SK287900B6/sk not_active IP Right Cessation
- 2002-01-02 HU HU0304062A patent/HU229305B1/hu unknown
- 2002-01-02 IL IL15702902A patent/IL157029A0/xx unknown
- 2002-01-02 DK DK02707413.7T patent/DK1363705T3/da active
- 2002-01-02 RU RU2003127077/04A patent/RU2303038C2/ru active
- 2002-01-02 PL PL02364279A patent/PL364279A1/xx unknown
- 2002-01-02 CZ CZ20032316A patent/CZ303750B6/cs not_active IP Right Cessation
- 2002-01-18 MY MYPI20020202A patent/MY137480A/en unknown
- 2002-01-23 TW TW091101013A patent/TWI318978B/zh not_active IP Right Cessation
- 2002-01-31 AR ARP020100336A patent/AR034292A1/es active IP Right Grant
- 2002-02-01 PE PE2002000075A patent/PE20020855A1/es not_active Application Discontinuation
2003
- 2003-07-21 IL IL157029A patent/IL157029A/en active IP Right Grant
- 2003-07-22 BG BG108021A patent/BG66359B1/bg unknown
- 2003-07-30 ZA ZA2003/05885A patent/ZA200305885B/en unknown
- 2003-07-30 IS IS6899A patent/IS2912B/is unknown
- 2003-08-01 NO NO20033436A patent/NO326510B1/no not_active IP Right Cessation
- 2003-09-01 HR HR20030694A patent/HRP20030694A2/hr not_active Application Discontinuation
- 2003-12-12 HK HK03109083.6A patent/HK1056698A1/xx not_active IP Right Cessation
2012
- 2012-09-12 CY CY20121100828T patent/CY1113194T1/el unknown

Also Published As

Publication number	Publication date
IS6899A (is)	2003-07-30
ZA200305885B (en)	2005-01-26
EP1363705A1 (en)	2003-11-26
PL364279A1 (en)	2004-12-13
RU2003127077A (ru)	2005-03-20
SK287900B6 (sk)	2012-03-02
AR034292A1 (es)	2004-02-18
WO2002062423A1 (en)	2002-08-15
EP1363705B1 (en)	2012-06-13
BRPI0206636B8 (pt)	2021-05-25
HRP20030694A2 (en)	2005-04-30
KR20030079979A (ko)	2003-10-10
ES2387981T3 (es)	2012-10-05
NO20033436L (no)	2003-10-01
TWI318978B (en)	2010-01-01
HU229305B1 (en)	2013-10-28
MY137480A (en)	2009-01-30
JP4328527B2 (ja)	2009-09-09
US20030069266A1 (en)	2003-04-10
NO326510B1 (no)	2008-12-22
EP1363705B9 (en)	2012-11-07
IL157029A (en)	2015-11-30
HK1056698A1 (en)	2004-02-27
EP1363705A4 (en)	2009-08-12
CZ303750B6 (cs)	2013-04-17
YU60903A (sh)	2006-05-25
HUP0304062A3 (en)	2010-06-28
MXPA03006939A (es)	2003-11-18
EE05424B1 (et)	2011-06-15
SK9592003A3 (en)	2004-08-03
CZ20032316A3 (cs)	2004-01-14
CY1113194T1 (el)	2016-04-13
CA2437524C (en)	2010-04-27
EE200300359A (et)	2003-12-15
PE20020855A1 (es)	2002-09-27
DK1363705T3 (da)	2012-09-24
RS52489B (en)	2013-02-28
CN1612763A (zh)	2005-05-04
BG66359B1 (bg)	2013-09-30
JP2004522755A (ja)	2004-07-29
RU2303038C2 (ru)	2007-07-20
BG108021A (bg)	2004-04-30
CA2437524A1 (en)	2002-08-15
IL157029A0 (en)	2004-02-08
BRPI0206636B1 (pt)	2018-05-02
CN100384423C (zh)	2008-04-30
NZ527193A (en)	2004-05-28
PT1363705E (pt)	2012-08-17
NO20033436D0 (no)	2003-08-01
BR0206636A (pt)	2004-02-25
HUP0304062A2 (hu)	2004-04-28

Publication	Publication Date	Title
IS2912B (is)	2014-11-15	Samsetning og andveiruvirkni umskiptra azaindóloxóediksýrupíperazínafleiðna
IS2919B (is)	2015-01-15	Samsetning og andveiruvirkni umskiptra azaindóloxóediksýrupíperazínafleiðna
NO20014409L (no)	2001-11-01	Dimere forbindelser og deres anvendelse som inhibitorer av neuraminidase
NO20033565L (no)	2003-10-13	Acylerte indanylaminer og deres anvendelse som farmasöytiske midler
DE50202479D1 (de)	2005-04-21	Saure pigmentdispergatoren und pigmentzubereitungen
DK1399153T3 (da)	2008-01-07	Farmaceutisk præparat indeholdende orlistat og en fedtsyre eller et salt deraf
DK1257276T3 (da)	2006-04-10	Antivirale azaindolderivater
DK1453517T3 (da)	2006-06-19	Farmaceutiske formuleringer med platinderivat
IS6934A (is)	2003-08-29	Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
NO20041272L (no)	2004-07-02	Tetracycline derivatives and methods of use thereof
ITMI20001732A0 (it)	2000-07-28	Composizioni farmaceutiche per il trattamento di mucositi e stomatiti
ATE390426T1 (de)	2008-04-15	Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate
DK1387838T3 (da)	2006-08-14	Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
NO20022007L (no)	2002-06-24	Krystaller av et oksyiminoalkansyrederivat og deres anvendelse som antidiabetika
IL163959A (en)	2010-12-30	Derivatives of phenyl-sulfonylamino- benzoic acid and pharmaceutical compositions comprising them
DK1228026T3 (da)	2004-04-05	15-Hydroxyicosatetraensyrerelaterede forbindelser og fremgangsmåde til anvendelse
EE200300454A (et)	2003-12-15	Bitsüklilised guanidiini derivaadid ja nende terapeutiline kasutamine
EE200100537A (et)	2002-12-16	Maduuraftalasiini derivaatide kasutamine proinflammatoorsete tsütokiinide inhibiitoritena
EE200300466A (et)	2003-12-15	Püridoindolooni derivaatide kasutamine ravimite valmistamiseks
SI1363705T1 (sl)	2012-10-30	Sestavek in antivirusna aktivnost substituiranih azaindoleoksoocetnih piperazinskih derivatov
DE60336549D1 (de)	2011-05-12	Hepatoprotektor aktivität von 2'-p-hydroxybenzoylmussaenosidsäure
TH103167B (th)	2010-08-11	สารผสมและแอคติวิตีต้านไวรัสของอนุพันธ์อะซาอินโดลออกโซอะซีติกพิเพอราซีนซึ่งถูกแทนที่
DK1232139T3 (da)	2005-10-03	Nervonsyrederivater, deres fremstilling og anvendelse